424Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Spain
Neuroscience Intelligence
Spain neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #8 of 50 · Data maturity A · Research score 49.0 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
112Recruiting trials
361Publications
284Institutions
Executive interpretation
Spain ranks #8 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC3116 recruiting
Hoffmann-La Roche216 recruiting
Novartis Pharmaceuticals113 recruiting
UCB Pharma100 recruiting
Hospital Universitari Vall d'Hebron Research Institute80 recruiting
Pfizer81 recruiting
Eli Lilly and Company80 recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau73 recruiting
Eisai Inc.74 recruiting
Boehringer Ingelheim60 recruiting
Disease activity
Parkinsons85trials
Alzheimers70trials
Epilepsy50trials
Pain Neuropathy23trials
Multiple Sclerosis21trials
Depression20trials
Other Neurology19trials
Stroke19trials
Neuromuscular16trials
Adhd14trials
Research institutions
Hospital General de CatalunyaOpenAlexlinked institution
Institute for Bioengineering of CataloniaOpenAlexlinked institution
Telefónica (Spain)OpenAlexlinked institution
Barcelona Supercomputing CenterOpenAlexlinked institution
Telefonica Research and DevelopmentOpenAlexlinked institution
Biomechanics Institute of ValenciaOpenAlexlinked institution
University Hospital HM Puerta del SurOpenAlexlinked institution
Centro Andaluz de Biología Molecular y Medicina RegenerativaOpenAlexlinked institution
Inmunal (Spain)OpenAlexlinked institution
Universidad San Pablo CEUOpenAlexlinked institution
Clinical evidence trail
NCT07842926Acute Effects of Capacitive-Resistive Radiofrequency Therapy in People With Parkinson's DiseaseRECRUITING
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07730671PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 CarriersNOT_YET_RECRUITING
NCT07654114Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X SyndromeRECRUITING
NCT07567261Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation and Expressive Writing for Post-Traumatic StressNOT_YET_RECRUITING
NCT07544498XR2ESILIENCE - XR-Based Resilience Training for Stress and Mental Health in Healthcare WorkersNOT_YET_RECRUITING
Research evidence trail
PUBMEDBeyond symptom resolution: Clinical burden and immunometabolic correlates of functional remission after mania.2027-01-01
PUBMEDThe role of physiotherapists in acute post-stroke neurorehabilitation: qualitative perspectives from clinicians and stroke unit managers.2026-12-31
PUBMEDLatent Space Projections and Atlases, a Cautionary Tale in Deep Neuroimaging using Autoencoders.2026-12-30
PUBMEDSymptom networks in manic and mixed presentations of bipolar disorder: Mapping the crossroads.2026-12-15
PUBMEDPlasma endocannabinoid levels in bipolar disorder: Differences between manic and euthymic states and the impact of cannabis use.2026-12-15
PUBMEDIn their own words: A qualitative focus group study of resilience in bipolar disorder.2026-12-15
PUBMEDMulti-Network Co-expression Analysis Enhances Biological Insights from Single-Cell Gene Expression.2026-12-01
PUBMEDPrenatal, Perinatal, and Postnatal Factors in a Cohort of Very Preterm and Very Low Birth Weight Toddlers with Suspected Autism Spectrum Disorder.2026-12-01
PUBMEDA Voxel-Wise T2 Distribution Framework for Lesion Severity Stratification and Treatment-Response Assessment in Stroke: Insights Into Suberoylanilide Hydroxamic Acid-Induced Neuroprotection.2026-12-01
PUBMEDStructured management of dopamine agonist withdrawal in restless legs syndrome with augmentation: A prospective real-world cohort study.2026-12-01
PUBMEDAttentionally directed oculomotor training produces disease-stage-dependent effects on plasma tau, cognition, and oculomotor signatures in patients with mild cognitive impairment.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.